Cnnm proteins and uses thereof

The present invention relates proteins from the group consisting of CNNM1, CNNM2, CNNM 3 and CNNM4, its derivatives or fragments thereof for use as a medicament, for treatment and or diagnostic purposes. The invention further relates to a human genomic DNA, cDNA or mRNA sequence encoding for a functional protein chosen from the group consisting of CNNM1, CNNM2, CNNM3 and CNNM4 and functional derivatives or fragments thereof.


Year:
2010
Other identifiers:
EPO Family ID: 42123173
TTO: 6.0861
Laboratories:




 Record created 2017-06-13, last modified 2018-01-27


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)